Skip to Main Content

Paper Details

<i>DUSP22</i> rearrangement is associated with a distinctive immunophenotype but not outcome in patients with systemic ALK-negative anaplastic large cell lymphoma.
Haematologica
10
2023
ALCL, ALK, ALK+, ALK-negative ALCL, ALK-negative anaplastic large cell lymphoma, ALKnegative, CD15, CD8, DUSP22, DUSP22-NR, DUSP22-NR neoplasms, DUSP22-R, DUSP22-R ALCL, DUSP22-R ALK-negative ALCL, DUSP22-R neoplasms, EMA, PD-L1, Patients, R ALCL, R ALK, TP63, TP63-R, Tyr705, granzyme B, pSTAT3 Tyr705, patients, stem cell
Author NameAffiliation
Francisco VegaThe University of Texas MD Anderson Cancer Center.
Pei LinThe University of Texas MD Anderson Cancer Center.
  • 1 - 2

Datasets

Release 1.2